TED-话题@MedSci

#TED#

72篇内容 | 2282人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1702960, encodeId=dba91e02960ca, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=Nintedanib治疗系统性硬化症相关性间质性肺病：已获得CHMP的积极评价, objectType=article, longId=189088, objectId=39b718908848, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39b718908848, replyNumber=0, likeNumber=87, createdTime=2020-08-18, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39b718908848, moduleTitle=Nintedanib治疗系统性硬化症相关性间质性肺病：已获得CHMP的积极评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39b718908848)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702954, encodeId=15a21e02954f5, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=NEJM：Nintedanib治疗系统性硬化性间质性肺病, objectType=article, longId=174366, objectId=d34f1e436665, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d34f1e436665, replyNumber=0, likeNumber=78, createdTime=2019-12-22, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d34f1e436665, moduleTitle=NEJM：Nintedanib治疗系统性硬化性间质性肺病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d34f1e436665)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702953, encodeId=f7691e0295389, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=LAFace洛美医疗联合创始人雷蒙德-道格拉斯发布TED新药物临床报告, objectType=article, longId=168858, objectId=5f7416885831, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f7416885831, replyNumber=0, likeNumber=67, createdTime=2019-09-21, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f7416885831, moduleTitle=LAFace洛美医疗联合创始人雷蒙德-道格拉斯发布TED新药物临床报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f7416885831)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702952, encodeId=4ee41e0295276, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=NEJM：Nintedanib系统性硬化相关的肺间质疾病的效果, objectType=article, longId=168676, objectId=cd361686e684, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd361686e684, replyNumber=0, likeNumber=86, createdTime=2020-01-18, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd361686e684, moduleTitle=NEJM：Nintedanib系统性硬化相关的肺间质疾病的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd361686e684)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702958, encodeId=1d991e02958a9, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=加拿大卫生部批准OFEV（nintedanib）用以缓解系统性硬化症相关ILD患者肺功能下降, objectType=article, longId=183715, objectId=fe2f183e1514, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe2f183e1514, replyNumber=0, likeNumber=70, createdTime=2019-12-27, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe2f183e1514, moduleTitle=加拿大卫生部批准OFEV（nintedanib）用以缓解系统性硬化症相关ILD患者肺功能下降, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe2f183e1514)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702955, encodeId=5b1d1e0295583, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=FDA批准nintedanib治疗与系统性硬化症相关的间质性肺病, objectType=article, longId=179152, objectId=816f1e9152ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=816f1e9152ed, replyNumber=0, likeNumber=69, createdTime=2019-12-06, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=816f1e9152ed, moduleTitle=FDA批准nintedanib治疗与系统性硬化症相关的间质性肺病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=816f1e9152ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702957, encodeId=df0b1e0295749, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=NEJM：nintedanib可以减缓间质性肺病患者肺功能的下降, objectType=article, longId=180874, objectId=d8701808e4d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8701808e4d2, replyNumber=0, likeNumber=92, createdTime=2020-03-11, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8701808e4d2, moduleTitle=NEJM：nintedanib可以减缓间质性肺病患者肺功能的下降, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8701808e4d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702950, encodeId=7cf71e02950f4, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=SCI 正式收录STTT《Signal Transduction and Targeted Therapy》, objectType=article, longId=157701, objectId=434115e701b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=434115e701b4, replyNumber=0, likeNumber=58, createdTime=2019-09-07, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=434115e701b4, moduleTitle=SCI 正式收录STTT《Signal Transduction and Targeted Therapy》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=434115e701b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702956, encodeId=1b7e1e0295622, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=2019年ERS：Nintedanib减慢纤维化间质性肺病的进展, objectType=article, longId=180637, objectId=7ff718063eac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ff718063eac, replyNumber=0, likeNumber=72, createdTime=2020-01-02, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ff718063eac, moduleTitle=2019年ERS：Nintedanib减慢纤维化间质性肺病的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ff718063eac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702951, encodeId=73131e02951b6, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=Zepsyre（lurbinectedin）在小细胞肺癌治疗中获欧洲药品管理局孤儿药认定, objectType=article, longId=158995, objectId=d85315899529, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d85315899529, replyNumber=0, likeNumber=68, createdTime=2019-02-10, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d85315899529, moduleTitle=Zepsyre（lurbinectedin）在小细胞肺癌治疗中获欧洲药品管理局孤儿药认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d85315899529)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702948, encodeId=10071e02948b6, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=ANN ONCOL：trabectedin治疗老年软组织肉瘤患者的有效性和耐受性, objectType=article, longId=150028, objectId=fb3e1500282b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb3e1500282b, replyNumber=0, likeNumber=70, createdTime=2019-09-15, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb3e1500282b, moduleTitle=ANN ONCOL：trabectedin治疗老年软组织肉瘤患者的有效性和耐受性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb3e1500282b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702946, encodeId=1d3d1e029462f, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=JCO：Lurbinectedin治疗BRCA突变转移性乳腺癌, objectType=article, longId=149919, objectId=11e714991947, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11e714991947, replyNumber=0, likeNumber=67, createdTime=2019-08-14, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11e714991947, moduleTitle=JCO：Lurbinectedin治疗BRCA突变转移性乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11e714991947)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702945, encodeId=86f41e0294500, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=J Endod：Twisted File Adaptive和Navigator EVO器械在不同运动模式下根管偏移、定心能力以及循环疲劳比较, objectType=article, longId=147077, objectId=d1c714e077dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1c714e077dc, replyNumber=0, likeNumber=72, createdTime=2019-02-21, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1c714e077dc, moduleTitle=J Endod：Twisted File Adaptive和Navigator EVO器械在不同运动模式下根管偏移、定心能力以及循环疲劳比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1c714e077dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702944, encodeId=67f91e0294445, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=Eiger制药宣布首例患者入组聚乙二醇化干扰素联合Ritonavir-Boosted Lonafarnib的II期LIFT研究, objectType=article, longId=146130, objectId=8c0f14613063, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c0f14613063, replyNumber=0, likeNumber=79, createdTime=2018-08-12, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c0f14613063, moduleTitle=Eiger制药宣布首例患者入组聚乙二醇化干扰素联合Ritonavir-Boosted Lonafarnib的II期LIFT研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c0f14613063)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702949, encodeId=755f1e02949ee, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=TED演讲 | 基因改造人类将在2030年成为现实？, objectType=article, longId=154489, objectId=51b81544894c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51b81544894c, replyNumber=0, likeNumber=61, createdTime=2019-07-19, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51b81544894c, moduleTitle=TED演讲 | 基因改造人类将在2030年成为现实？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51b81544894c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702941, encodeId=e6561e02941f7, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=nintedanib对恶性胸膜间皮瘤的有效性, objectType=article, longId=138660, objectId=4ae8138660ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ae8138660ec, replyNumber=0, likeNumber=85, createdTime=2018-06-03, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ae8138660ec, moduleTitle=nintedanib对恶性胸膜间皮瘤的有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ae8138660ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702947, encodeId=faea1e02947dc, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=ANN ONCOL：Nintedanib治疗难治性转移性结直肠癌, objectType=article, longId=149951, objectId=509f149951c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=509f149951c3, replyNumber=0, likeNumber=82, createdTime=2019-04-23, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=509f149951c3, moduleTitle=ANN ONCOL：Nintedanib治疗难治性转移性结直肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=509f149951c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702942, encodeId=944b1e0294255, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=J Endod：WaveOne Gold往返及Twisted File自适应系统预备弯曲根管中碎屑推出根尖孔的比较, objectType=article, longId=141720, objectId=b4e3141e20c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4e3141e20c3, replyNumber=0, likeNumber=85, createdTime=2019-03-30, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4e3141e20c3, moduleTitle=J Endod：WaveOne Gold往返及Twisted File自适应系统预备弯曲根管中碎屑推出根尖孔的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4e3141e20c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702943, encodeId=b76f1e0294362, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=美国食品和药物管理局（FDA）已授予PharmaMar的Lurbinectedin孤儿药物认定, objectType=article, longId=145959, objectId=fbd114595986, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbd114595986, replyNumber=0, likeNumber=74, createdTime=2019-03-17, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbd114595986, moduleTitle=美国食品和药物管理局（FDA）已授予PharmaMar的Lurbinectedin孤儿药物认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fbd114595986)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1702938, encodeId=811c1e0293803, content=<a href='/topic/show?id=72351e25437' target=_blank style='color:#2F92EE;'>#TED#</a>, objectTitle=重复 JAMA Neurol：高龄、亚洲人、严重卒中更能够从低剂量阿替普酶中获益(ENCHANTED研究)？, objectType=article, longId=122553, objectId=6c4e12255399, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c4e12255399, replyNumber=0, likeNumber=72, createdTime=2018-11-22, rootId=0, userName=aliceclz, userId=76e230462388, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c4e12255399, moduleTitle=重复 JAMA Neurol：高龄、亚洲人、严重卒中更能够从低剂量阿替普酶中获益(ENCHANTED研究)？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c4e12255399)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

TED

2020-05-29

aliceclz (审核中...)

前往app查看评论内容

#TED#

Nintedanib治疗系统性硬化症相关性间质性肺病：已获得CHMP的积极评价

2020-08-18

仁医06 (审核中...)

前往app查看评论内容

#TED#

NEJM：Nintedanib治疗系统性硬化性间质性肺病

2019-12-22

aliceclz (审核中...)

前往app查看评论内容

#TED#

LAFace洛美医疗联合创始人雷蒙德-道格拉斯发布TED新药物临床报告

2019-09-21

aliceclz (审核中...)

前往app查看评论内容

#TED#

NEJM：Nintedanib系统性硬化相关的肺间质疾病的效果

2020-01-18

aliceclz (审核中...)

前往app查看评论内容

#TED#

加拿大卫生部批准OFEV（nintedanib）用以缓解系统性硬化症相关ILD患者肺功能下降

2019-12-27

aliceclz (审核中...)

前往app查看评论内容

#TED#

FDA批准nintedanib治疗与系统性硬化症相关的间质性肺病

2019-12-06

aliceclz (审核中...)

前往app查看评论内容

#TED#

NEJM：nintedanib可以减缓间质性肺病患者肺功能的下降

2020-03-11

aliceclz (审核中...)

前往app查看评论内容

#TED#

SCI 正式收录STTT《Signal Transduction and Targeted Therapy》

2019-09-07

aliceclz (审核中...)

前往app查看评论内容

#TED#

2019年ERS：Nintedanib减慢纤维化间质性肺病的进展

2020-01-02

aliceclz (审核中...)

前往app查看评论内容

#TED#

Zepsyre（lurbinectedin）在小细胞肺癌治疗中获欧洲药品管理局孤儿药认定

2019-02-10

aliceclz (审核中...)

前往app查看评论内容

#TED#

ANN ONCOL：trabectedin治疗老年软组织肉瘤患者的有效性和耐受性

2019-09-15

aliceclz (审核中...)

前往app查看评论内容

#TED#

JCO：Lurbinectedin治疗BRCA突变转移性乳腺癌

2019-08-14

aliceclz (审核中...)

前往app查看评论内容

#TED#

J Endod：Twisted File Adaptive和Navigator EVO器械在不同运动模式下根管偏移、定心能力以及循环疲劳比较

2019-02-21

aliceclz (审核中...)

前往app查看评论内容

#TED#

Eiger制药宣布首例患者入组聚乙二醇化干扰素联合Ritonavir-Boosted Lonafarnib的II期LIFT研究

2018-08-12

aliceclz (审核中...)

前往app查看评论内容

#TED#

TED演讲 | 基因改造人类将在2030年成为现实？

2019-07-19

aliceclz (审核中...)

前往app查看评论内容

#TED#

nintedanib对恶性胸膜间皮瘤的有效性

2018-06-03

aliceclz (审核中...)

前往app查看评论内容

#TED#

ANN ONCOL：Nintedanib治疗难治性转移性结直肠癌

2019-04-23

aliceclz (审核中...)

前往app查看评论内容

#TED#

J Endod：WaveOne Gold往返及Twisted File自适应系统预备弯曲根管中碎屑推出根尖孔的比较

2019-03-30

aliceclz (审核中...)

前往app查看评论内容

#TED#

美国食品和药物管理局（FDA）已授予PharmaMar的Lurbinectedin孤儿药物认定

2019-03-17

aliceclz (审核中...)

前往app查看评论内容

#TED#

重复 JAMA Neurol：高龄、亚洲人、严重卒中更能够从低剂量阿替普酶中获益(ENCHANTED研究)？

2018-11-22

科室
- - 订阅+
  - 更多科室
工具
服务